Jeff Boyd
Corporate Functions Team
BACKGROUND
FOCUS AREAS
More than 25 years of leadership experience spanning pharmaceutical services and CDMOs, biopharma and advanced therapies, and global consulting and advisory.
• CDMO strategy, growth, and transformation
• Pharmaceutical manufacturing and technical operations
• Cell & gene and advanced therapies
• Quality, compliance, and GxP operations
• Commercial strategy and growth
• Executive leadership and organizational transformation
Jeff Boyd leads ELIQUENT’s global CDMO business, bringing together the firm’s Regulatory, Quality & Compliance, and GxP Engineering capabilities to help pharmaceutical services companies solve complex manufacturing and development challenges, improve performance, and accelerate growth.
Jeff Boyd is a senior life sciences executive with more than 30 years of experience spanning pharmaceutical services and CDMOs, biopharmaceutical manufacturing and commercialization, and global consulting and advisory.
Jeff began his career in life sciences manufacturing and operations before spending more than a decade with Lonza, where he held increasingly senior leadership roles across global operations, pharmaceutical manufacturing, and cell and gene therapy services. His experience included leading and scaling CDMO operations, supporting clients ranging from emerging biotechnology companies to global pharmaceutical organizations, and overseeing manufacturing networks across the United States, Europe, and Asia.
He subsequently joined Novartis, where he served as Vice President and Head of Technical Operations for Cell & Gene Therapies. In that role, Jeff led manufacturing, supply chain, manufacturing science and technology, engineering, and related operations supporting the development and commercialization of novel cell and gene therapies. He played a leadership role in the technical transfer, scale-up, regulatory readiness, and commercial launch of Kymriah, the first FDA-approved CAR-T therapy.
Most recently, Jeff was Global Managing Partner of Healthcare & Life Sciences at Heidrick & Struggles. He advised CEOs, boards, and senior executives across biopharmaceuticals, life sciences tools and services, medical technology, and healthcare services, with particular depth in CDMOs, manufacturing, supply chain, CMC, and advanced therapeutic modalities.
Across his career, Jeff has worked at the intersection of science, operations, commercial strategy, and leadership—helping organizations translate innovation into scalable operations and ultimately bring important therapies to patients.
-
EDUCATION:
Bachelor of Arts, Communication, University of Tennessee
Masters of Business Administration, Frostburg State UniversityASSOCIATIONS:
Board of Visitors, University of Tennessee College of Communication & Information
-
Areas of Expertise:
• Pharmaceutical services and CDMO strategy, operations, and commercial growth
• Pharmaceutical manufacturing and global technical operations
• CMC strategy, technology transfer, scale-up, and commercialization
• GxP manufacturing, quality, compliance, and regulatory readiness
• Cell & gene therapy and advanced therapeutic modalities
• Manufacturing network strategy, supply chain, and operational excellence
• New product introduction and launch readiness
• Organizational design, transformation, and leadership
• Executive, C-suite, and board advisory
• Business development and strategic client partnerships
• M&A integration and operational transformationSelected Professional & Leadership Experience:
• Eliquent Life Sciences — Senior leadership focused on the CDMO sector and GxP consulting and implementation
• Heidrick & Struggles — Global Managing Partner, Healthcare & Life Sciences; previously Regional Managing Partner, Americas, Healthcare & Life Sciences and Partner
• Novartis — Vice President & Head of Technical Operations, Cell & Gene Therapies
• Lonza — Senior global leadership roles spanning pharmaceutical operations, CDMO operations, operations support, and organizational leadership
• Thermo Fisher Scientific — Senior Manager, Warehousing & Logistics
• Cambrex — Cell Culture Media Manufacturing ManagerSelected Industry Experience:
• Led technical operations supporting the development, regulatory approval, and commercial launch of Kymriah, the first FDA-approved CAR-T therapy
• Led and scaled CDMO operations supporting clients ranging from emerging biotechnology companies and academic institutions to global pharmaceutical companies
• Managed global manufacturing and operations across the U.S., Europe, and Asia
• Experience engaging global health authorities, including the FDA, in support of IND, BLA, pre-approval inspection, and commercialization activities
• Advised CEOs, boards, and senior executives across biopharmaceuticals, CDMOs, life sciences tools and services, medical technology, and healthcare services
Ready for regulatory clarity? Contact Us.
(* Indicated fields are mandatory.)